# Sentinel Node Mapping in High Risk Endometrial Cancer

> **NCT03366051** · NA · RECRUITING · sponsor: **AC Camargo Cancer Center** · enrollment: 178 (estimated)

## Conditions studied

- Endometrial Cancer
- Lymph Node Metastases

## Interventions

- **PROCEDURE:** Sentinel Node Mapping
- **PROCEDURE:** Lymphadenectomy

## Key facts

- **NCT ID:** NCT03366051
- **Lead sponsor:** AC Camargo Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-12-22
- **Primary completion:** 2024-12-20
- **Final completion:** 2024-12-20
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03366051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03366051, "Sentinel Node Mapping in High Risk Endometrial Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03366051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*